By Larry Romanoff, February 05, 2022
ENGLISH CHINESE POLSKI
PORTUGUESE SPANISH
It may surprise you to learn that the pharmaceutical
industry has the dirtiest underbelly of all recognised economic sectors in the
world today, so totally riddled with crime and corruption that it probably
cannot be fixed. As one measure, in the past few decades Big Pharma has created
a toll of deaths and injuries exceeding that of all the world’s arms
manufacturers combined. Astonishing claims, but heavily documented and easily
proven. The reason you don’t know is that the world’s mainstream media are
owned by very close friends of these drug lords and, while most of the
information on the legacy of crimes and misery is not exactly heavily censored,
the exposed crimes are treated in the media as unrelated one-off events instead
of forming parts of a pattern of astonishing psycho-pathology that has existed
for decades, while ensuring that the ultimate beneficial owner-criminals are
almost never identified.
Even a company like Nestlé, who are not a drug
company but who are heavily invested in related products like baby milk, are
responsible for millions of infant deaths, (1) again heavily protected by the world’s legacy
media. All of this information is easily available on the second or third tier
of the internet, but too few people traverse these sites and their
documentation is inevitably trashed as “misinformation” or “conspiracy
theories”. Sadly, it is no such thing. Pharma companies repeatedly fail to warn
doctors and patients about dangerous side-effects or long-term dangers of
medications, and very often badly misrepresent the content and efficacy, to say
nothing of the safety, of vaccines.
One fatal misconception we tend to hold is that
pharmaceutical companies are in the “healthcare” business or the
“disease-prevention” business. They are not. They are in the money business. It
may be a surprise to you that there is no money in curing a disease; the
profits are in long-term maintenance. It occurs only rarely that a genuine –
and permanent – cure for a disease is actually discovered and put into effect.
Malaria is a disease that kills hundreds of
thousands worldwide every year, yet a cure is available. There are two
problems: one is that Malaria is a disease of poor countries who are of little
or no concern to anyone; the second is that the cure is generic, cheap and
unprofitable. Vaccines generally, and a great many other medications, are
extremely profitable, obscenely so in many instances, and pharma companies
responsible to their shareholders (and they are) focus on revenue and
profitability, not on saving lives. It is only when an entire nation panics at
the prospect of a deadly illness (polio, for e.g.) that a genuine cure will be
found and distributed. As noted, these events are not frequent, and there is
much accumulated evidence that pharma companies will abandon a search for a
cure and focus instead on medications that will keep a disease at bay – medications
requiring daily ingestion and thus producing much profit. (2)
Most often, alarmingly often in fact, a dangerous or
lethal drug or vaccine will be recalled only when lawsuits are filed by the
victims; the US FDA, the CDC, and other national health agencies ignoring the
trail of bodies and infirmities until then. The history of recent decades is
replete with such examples. And even after withdrawal, the pharma companies
will continue to market the same drugs, vaccines, and medical appliances in
poorer countries, with the apparent full blessing of the FDA and CDC. It would
seem that black lives (and yellow ones, too) don’t matter nearly as much as we
are told. I have some examples of this for you, that are at once horrific,
appalling, and truly shocking. The sociopathic travesties visited on both the
Western world and the Third World by the pharma companies, the UN agencies,
national healthcare organisations and Western governments, leave us reeling in
disbelief.
It is very important to understand that it isn’t
only the pharma companies; the US FDA and CDC inevitably fail to warn the
public until the lawsuits commence, heavily supported by both the US government
and the Western media. One clear example is the polio vaccine that
was contaminated with a carcinogenic simian virus where around 100 million
Americans were infected. (3) (4) Of course, “fact-checking” websites like Snopes
found the claim false, but it wasn’t false. According to Pubmed, “The presence
of SV40 in monkey cell cultures used in the preparation of the polio vaccine
from 1955 through 1961 is well documented.” True to form, the Lancet
politicised this and blamed it on the Russians, neglecting to mention that the
vaccines were primarily created and distributed in – and by – the US. However,
the Lancet was honest enough to note that the person who discovered this
looming tragedy “was muzzled and stripped of her vaccine regulatory duties and
her laboratory” (5) – by the Americans who treasure
whistle-blowers (in other countries). More than 25 studies confirming
the correlation between the contaminated vaccines and cancer were refused for
publication by the US NIH. Lawsuits against Pfizer and others for this
CDC-approved vaccine are still pending.
Something similar is true for polio. Few
people are aware that most cases of polio today are the result of WHO polio
vaccination campaigns and not from any natural spread of the disease. The
WHO uses oral polio vaccines because they are cheap and can be easily
administered, but it is these same vaccines administered worldwide by the WHO
that have proven responsible for the increasing recurrence of polio in many
countries. (6) Many more polio cases today are caused by the WHO’s
reckless vaccination campaigns than by other causes. An independent medical
group tasked with monitoring these events, wrote that polio (because of the WHO
practices) was “spreading uncontrolled in West Africa, bursting geographical
boundaries and raising fundamental questions . . .” It further described the
WHO’s attitude toward terminating this pandemic of vaccine-caused polio cases
as “relaxed”. (See above reference). I might have used a stronger term.
Another
Cloud in the Silver Lining
There is something else you should know – the
incestuous relationship between the big pharmaceutical companies and the US
Department of Defense and the CIA, all cozy partners in biological weapons
programs. This shouldn’t actually be a surprise; pharma companies spend
their lives fabricating new chemicals and testing their effects on the human
body. Since even the drugs and vaccines they put on the market are often toxic
and lethal, it’s natural that at least some of their Franken-drugs will prove
to be especially so, thus attracting the eager interest of the weapons
people. The military are particularly interested in concoctions that
will kill in large numbers while the CIA are more tuned to one-off
assassinations, especially those that mimic natural heart attacks or strokes. Ask
Mossad. Thus, it should not be a surprise that many compounds which
today find their way into the American biological weapons inventory are termed
“orphan pharmaceuticals”, which means drugs proven to have such extraordinarily
toxic properties that they became much too valuable to discard.
In most of these cases, “plausible deniability” is
an extravagant plus, a drug, a chemical – or a virus – that is easy to
distribute but difficult to attribute to a foreign agent, one which could
possibly have emerged by natural means, courtesy of Thomas Malthus. Some
examples that come to mind would be SARS, MERS, EBOLA, AIDS, ZIKA, H1N1, Swine
flu, and Mad Cow Disease. And COVID-19, if you’re the suspicious type.
It isn’t a stretch to know and accept that many
pharma companies do precisely such research for the US military, looking not
only for drugs that cure but for drugs (or viruses and vaccines) that kill,
especially those that can debilitate or kill in large numbers. Big Pharma has
been involved in this morally-bankrupt adventure for almost 100 years, Pfizer and
Merck having their beginnings in the world of bio-weapons. I will deal with
these later.
The set of circumstances outlined here is true in
every Western nation. Governments, national healthcare authorities and UN
agencies like the WHO and UNICEF are active participants in this sociopathic
enterprise, all circling the wagons for self-protection and leaving the publics
to cope as best they can. If the bad news leaks out, denial and censorship are
the main tools, while muzzling, threats and retribution are the order of the
day for whistle-blowers. In today’s climate we have the added advantage of
de-platforming on Twitter and Facebook for “spreading misinformation”,
and total censorship on Google who loses its memory whenever corporate and
government crimes appear.
These pages will give you only a brief glimpse of
the pharmaceutical landscape that exists today, one so rife with
corruption of every kind and littered with a reckless disregard for human life
and suffering that is almost impossible to believe at first reading. I will
provide in this section a short burst of examples, then a series of longer case
studies which are especially serious. This latter will include Pfizer, Johnson
& Johnson, Merck, GSK and Bayer.
A
Brief Sampling
AstraZeneca
In 2003, AstraZeneca pleaded guilty to felony
charges of health care fraud and was forced to pay $355 million to settle both
criminal and civil liabilities for a nationwide illegal marketing scheme that
included gross inflation of drug prices, bribery, kickbacks, fraudulent
consulting fees and bribes to physicians. (7) Noteworthy that the
government refused to file criminal charges against company executives because
”The investigation did not discover any evidence to implicate AstraZeneca’s
upper levels of management”. What a surprise; the “corporate entity” committed
serious felonies over a decade but no live persons were involved, and certainly
not the management. In 2011 AstraZeneca agreed to pay $647 million to resolve
most of the 28,000 lawsuits it faced for diabetes and other injuries
caused by its antipsychotic drug Seroquel. (8)
In 2021, the European Union launched a new lawsuit
against AstraZeneca that could lead to financial sanctions for the company, the
second such suit in a year. (9) AstraZeneca has a long list of
accusations, charges, and lawsuits about illegal marketing, product safety,
anticompetitive behavior and tax avoidance, a typical criminal
organisation. You can read all about it here: (10)
Abbott
Laboratories
Abbott Laboratories paid $1.6 billion to settle
charges for off-label marketing and false efficacy claims related to its
epilepsy drug Depakote which caused, among other things,
severe birth defects. (11) (12) The claims stated that Abbott not only heavily
engaged in illegal off-label promotion, but targeted elderly patients and
misled physicians about the risks it had clearly identified in its own clinical
studies. True to form, the FDA did nothing for many years, until finally “a
huge accumulation of evidence” forced the agency to place a warning on the
drug, but it did so only after an independent study revealed that 20%
of pregnant mothers experienced births with severe malformities including spina
bifida and heart and brain defects. In total, Abbott has been
charged with a wide array of crimes including fraudulent marketing,
price-fixing, anti-competitive conduct, fraudulent claims, fraudulent pricing,
and the marketing of toxic and lethal medications.
In addition to its fines and other penalties, Abbott
was forced to cease the manufacture of more than 125 products and to remove
them from the market. The company has faced lawsuits over its drug Tricor,
FreeStyle diabetes products, and a massive class-action suit over its St. Jude
defibrillators which featured rapidly-depleting batteries resulting in
un-defibrillated hearts. In this latter case, the company waited almost
five years before initiating a recall of the faulty devices. (13) A few years earlier, TAP Pharmaceuticals, a JV of
Abbott, paid $875 million to settle essentially the same charges as AstraZeneca
above, felony charges of bribery and illegal marketing.
Abbott’s cholesterol drug Trilipix received
hearty FDA approval in spite of the proven fact from a large body of evidence
that it was not only useless but failed to prevent and sometimes caused
the heart attacks it was promoted to prevent. As usual, the FDA finally
issued a belated warning that was unhelpful to the already-dead victims.
Similarly, Abbott’s new “lifestyle drug” Androgel, marketed as a
testosterone supplement with FDA approval for only this narrow use, was
quickly engaged in a $100 million off-label campaign promoting the drug for
conditions as vacuous as ‘fatigue’. Since the medication cost about $500
per month and produced enormous profits from sales exceeding $1 billion per
year, the company was loathe to reveal the slate of potentially lethal side
effects of which it had full knowledge. Abbott marketed Androgel to
millions of men who didn’t need it and hid the risks of heart attack and stroke
associated with the drug. (14)
Media reports claimed the drug had barely hit the
market when physicians noted a direct link to heart attacks and strokes, and
apparently this drug had a long history of linkage to cardiovascular problems.
Interestingly, 14 separate and independent studies revealed substantial cardiac
risk while another 13 studies conducted by pharma companies disclosed no risk
at all. There appeared little question the pharma companies produced what were
in fact criminally-misleading studies that deliberately omitted lethal dangers,
resulting in large class-action lawsuits in many countries.
The media also reported another US Federal legal
action against Abbott and its Israel-based partner Teva for illegally blocking
consumer access to low-cost generic medications by filing “baseless patent
infringement lawsuits against many competitors, solely to delay their entry to
the market and to protect the massive profits”. As well, Teva
apparently made an illegal agreement with Abbott to withhold its generic
version from the market in return for permission to market another
highly-profitable drug controlled by Abbott. (15)
In another dispiriting case, in 2010 Abbott
was forced to recall large volumes of Similac baby milk powder which
contained beetles, beetle feces and various insect parts, leading to
yet more consumer class action lawsuits. (16) (17) (18) The FDA, always there when you need them, took no
action but surprisingly stated that “Abbott’s sanitation and quality control
measures left much to be desired”.
One writer recorded the following. I am uncertain of
the source:
“In all the recent history of American pharma companies we see the same unsavory behavior, if not outright criminal intent, in every major area of endeavor. In 2012 Abbott employees launched a class action suit against the company for refusing to pay overtime, the company having classified thousands of employees as exempt from compensation when the law apparently disagreed. A few years earlier, another major class action was filed against Abbott from its treatment of staff during a spin-off of its hospital products division, where staff who would have been entitled to earn substantial employee benefits through the spin-off and transfer were instead terminated and rehired primarily to escape this expense. And with many pharma companies, including Abbott again, there has been no shortage of class action civil suits by shareholders repeatedly claiming the firms violated securities laws to the disadvantage of shareholders.”
Hoffmann-La
Roche
Hoffman La Roche has had to pay out nearly $2
billion in judgments and fines over the years, to say nothing of facing
thousands of individual lawsuits and class-action cases. The company was fined
$500 million for being the instrumental leader of “a worldwide conspiracy to
raise and fix prices and allocate market shares for vitamins sold in the United
States and internationally”, a conspiracy apparently lasting for about
ten years. (19) And yet a headline in a dutiful corporate
apologia in the New York Times said, “Roche Officers Say
Scandal Is a Surprise”. Well, it’s a surprise to me this was a surprise to
them, the entire corporate executive structure apparently blissfully unaware of
their actions over ten years.
Roche has also had its share of FDA-approved toxic
medications with side effects that typically included death. One of these was
the not-so-wonderful and often useless drug Tamiflu, which was
credited with a flock of deaths of children in Japan and which resulted in a
warning by Japan’s Health Ministry to not administer this drug to those under
20 years of age. (20) Roche’s Prosicor was withdrawn
from the market after about 150 deaths revealed a fatal
incompatibility with other medications. In Japan again, Roche
discovered its arthritis medicine Actemra had a habit of killing
patients, and the company had to cancel trials for another arthritis drug
that tended to produce serious infections, more than 1,000 of which were fatal.
(21)
In 2014, the Guardian reported that Roche was
excoriated by the UK government for charging over $140,000 for doses of
a breast cancer drug that at best promised a few extra months of life to
patients. The company’s response, issued by Roche’s general manager, the
undoubtedly fine and caring physician Dr. Jayson Dallas, was that the UK’s
health system and drug regulation were “broken”. Not incidentally, it was
executives and lobbyists of Roche who were deeply involved in establishing the
UK’s cancer drugs fund, primarily because Roche would be the biggest
beneficiary of that fund. The company now complains that its inability to drain
the entire fund is a prima facie sign of the system being “broken”.
In 2012, Roche was under criminal investigation by
authorities in the UK, the US and Europe for its failure to disclose some
80,000 reports of side effects from its medicines, including more than 15,000
patient deaths, resulting in Chinese medical authorities immediately opening
their own investigation. It was interesting to read the foolish dissembling
Roche used in dismissing Chinese concerns:
“The company’s China executives denied that its drugs have serious side effects”, 80,000 adverse reactions and 15,000 deaths apparently not qualifying as “serious”. Roche’s China executives admitted the same drugs are sold in China, but are treating different conditions in a different market, which means the side effects may be different. So, if my headache painkiller kills you instead, the result may be different if you take the drug for a toothache. And, since different markets have different reactions, the drug may kill you in Tianjin but may cause only headaches in Xi’An. And, finally, “There is no rule in China on compensation paid by pharmaceutical firms to victims of drug side effects.” So, no worries anyway.
Sanofi,
Sanofi-Pasteur, Sanofi-Aventis, Sanofi-Connaught Laboratories Canada
This
Rothschild-owned hydra is the world’s largest vaccine manufacturer, among other
things. Sanofi was
recently in the news following a years-long investigation resulting in planned
criminal charges for manslaughter due to their marketing of a drug named Depakine which
was taken by pregnant mothers and apparently resulted in as many as 30,000
stillborn fetuses or infants with serious deformities. (22) (23) (24) Authorities charged the company with
“aggravated deception” but, according to Reuters, is still prescribed in more
than 100 countries, news apparently not travelling due to media sympathy.
A few years back, Sanofi-Aventis was forced to pay
more than $180 million plus interest to resolve lawsuits related to
illegal price-gouging, the US government apparently heavily
overpaying for years for a cancer medication. (25)
Around the same time, Sanofi earned another lawsuit
for a massive kickback and bribery scheme that funneled tens of millions of
dollars as incentive to prescribe the company’s diabetes drugs. This
resulted from a whistle-blower lawsuit claiming the company’s CEO “was involved
in the aforesaid illegal and/or fraudulent activity” which went on “over the
course of many years.” (26) The kickbacks may have involved more than “tens of
millions” of dollars, since the lawsuit also claimed that “approximately
$1 billion is missing” from Sanofi’s bank account. Employees also claimed
to have been aware of “many instances” where Sanofi or its lawyers destroyed
documents to prevent them from falling into the wrong hands. (27)
The
Sanofi employee who brought this to light (the whistle-blower) was immediately
fired for doing so. (28) Her statements were denounced by Sanofi as being
“without merit”, and further were “false, scandalous and unsupported by any
evidence.” The company claimed “Diane Ponte is a disgruntled … employee who is
opportunistically attacking our company.” Shame on her.
In related news, this was the second massive
bribery-kickback scheme at Sanofi, occurring only two years after the US
Justice Department forced the company to pay more than $100 million for
essentially the same crime. In more related news, Sanofi was heavily
fined in yet another bribery scheme for a multiple-sclerosis drug that
sold for more than $100,000 per patient per year. (29) And there was much more, including illegal
interference in the marketing of generic medications. (30) In another case, Sanofi is in court for failure to
warn that their drug Taxotere could cause permanent eye injuries, a
fact well-known by the company but not disclosed. (31) In yet another case, a US judge said the company
“engaged in deceptive practices” in failing to warn of severe known
health risks in a blood thinner, levying a fine of about $835 million.
(32) In yet another court case, Sanofi-Pasteur was
forced to pay more than $60 million for illegal violation of pediatric
vaccines. (33) In yet other cases, Sanofi was fined $109
million in the US and $40 million in Germany for paying bribes. (34) (35) The list is long.
After these settlements, Sanofi was forced to sign a
“corporate integrity agreement” with the US government in which the company was
required to abide by the laws and to report illegal activities by the company
and its employees. I have no doubt Sanofi will adhere religiously to this
agreement.
Medtronic
“Medtronic, which bills itself as an “immensely
successful medical devices company”, has had a bit of a troubled history with
those same ‘successful’ devices, and has been excoriated in professional
journals for its “cozy relationship” with doctors, providing them with research
payments and consulting fees to report on their research and on the company’s
products.”
The
company is famous for the gigantic fraud on its bone fusion product
called Infuse Bone Graft where
its clinical studies either ignored entirely or downplayed serious adverse
complications from using the product in spinal fusion surgery. (36) In all, 15 surgeons published 13 clinical
studies for Medtronic that praised the product while failing to report any
adverse reactions, which occurred about 50 times more often than stated in the
so-called “peer-reviewed” journals. The other thing they failed to
mention was that Medtronic had paid each of them from $12 million to $16
million for each supposedly unbiased study, (37) but the corporate apologists claimed these
payments would have had no effect on either the doctors’ scientific appraisal
or on the content of their reports. Industry insiders have testified that these
firms often corrupt their own experimental data, recording fabricated
results to justify marketing a profitable but toxic, or even lethal, product.
Medtronic
has also had consistent quality problems with its electronic pacemakers,
related to batteries, circuitry wiring and more, with a history of past recalls and safety issues.
In 2005, the company issued a recall for one series of defective pacemakers
that had wiring problems causing the device (and hearts) to fail. (38) As well, Medtronic encountered serious
difficulties with a defective defibrillator that could either impart excessive
shocks or fail to work at all, with more than 100 deaths having been
reportedly caused.
But then, in the middle of federal litigation, fate
intervened when a US Federal judge ruled that Medtronic had no liability for
its defective products because they had been approved by the FDA, and the
company was therefore immune from prosecution. This is the same FDA who
legislated that pharma companies are not liable for death or injury from
defective medications – even if it is proven that they lied in their
applications and fabricated all their test data. The judge in this case
ruled that the only remedy for injured or deceased patients laid with the FDA
– who is itself immune from prosecution. To further feather the corporate
nest, the US GAO – the Government Accountability Office – ruled that
the FDA was not in fact accountable for anything since it was “not
capable” of ensuring the safety of medical devices and had no ability to
conduct inspections in any case. So there we are. No liability
anywhere.
Takeda
Pharmaceuticals
In 2015, the Japanese pharma company Takeda was
forced to pay about $2.5 billion to settle criminal and other claims that it
failed to warn patients about a serious cancer risk associated with one of its
diabetes drugs, from which apparently about 10,000 patients
developed bladder cancer. Then Takeda was forced to pay another $6 billion
for the same crime. (39) Both France and Germany had already determined the
drug was associated with high cancer risk, and the US FDA had come to a similar
conclusion. As usual, Takeda defended both its drug and its marketing by
claiming “the benefits outweighed the risks”, failing to note that this
particular medication was a cash cow for the company, generating sales of about
$4 billion per year. Nevertheless, Takeda said it believed “the plaintiffs’
claims were without merit”, and the company refused to admit any liability for
the fatal side effects, but said it said it agreed to the $2.5 billion
settlement just to “reduce financial uncertainties” and permit it to focus its
attention on developing new ‘life-saving’ medications. I think that for $2.5
billion, most companies could live happily with some uncertainty.
Maxim
Healthcare
The Baltimore Sun reported that Maxim Healthcare,
one of the largest providers of home healthcare services in the US, was forced
to pay $150 million to settle civil and criminal charges for fraud in 43
states. (40) The company submitted more than $60 million in
false claims, defrauded Medicare and insurance companies of millions of dollars
by charging for work it never performed. Investigators said “Maxim repeatedly
modified time sheets and documents to cover up the fraud, creating a culture in
which submitting false claims became ‘common practice’.” In addition to the
fines, Maxim also has been charged with criminal conspiracy to commit fraud,
and this wasn’t the company’s first encounter with the law.
Pharma
Company Fines and Penalties
Below is a brief listing, by no means complete or up
to date, of some of the larger fines and penalties by some of the more
prominent pharma companies. At the time of writing there were dozens of
class-actions and countless tens of thousands of individual lawsuits pending
resolution and which would easily involve some tens of billions of dollars in
additional criminal fines, legislative and regulatory penalties, and civil
judgments.
Johnson
& Johnson
2010 – $80 million
2012 – 41.5 million
2013 – $2.3 billion
2021 – $26 billion (J&J + 3 distributors)
Pfizer
2004 – $430 million
2009 – $2.3 Billion
2012 – $825 million, $491 million, $257 million
2012 – $234 million, $164 million, $68 million
2012 – $60 million, $55 million, $43 million, $5
million
2014 – $273 million, $15 million, $13 million
AstraZeneca
2003 – $355 million
2003 – $875 million
2010 – $520 Million
2010 – $198 million (25,000 lawsuits)
2011 – $647 million
Hoffmann-La
Roche
1999 – $500 million
Total – about $2 billion
Sanofi
2007 – $183 million
2012 – $109 million
2012 – $40 million
2018 – $61 million
2020 – $12 million
2021 – $834 million
GSK
2003 – $90 million
2010 – $750 million
2012 – $490 million
2012 – $3 billion
Merck
2005 – $4.5 billion
2008 – $650 million
2010 – $950 million
2012 – $650 Million
Abbott
Laboratories
1999 – $100 million
2001 – $875 million (TAP Pharmaceutical)
2003 – $622 million
2005 – Abbott/Geneva – $18 million
2010 – Abbott/Braun – $421 million
2012 – $1.6 billion
Baxter
Healthcare/Israel-based Teva
1994 – $4 billion (Baxter, Dow Corning,
Bristol-Meyers)
1995 – $160 million, $3.3 billion (Caremark)
2004 – $3.3 million
2006 – $40 million
2008 – $500 million
2010 – $64 million, $165 million
2011 – $400,000, $625,000
Bayer
2003 – $1.13 billion
2003 – $250 million
2004 – $66 million
2004 – $33 million
2006 – $55 million and $18 million
Bristol-Myers
Squibb
1999 – $30 million
2003 – $670 million, $63 million
2004 – $150 million
2005 – $300 million
2006 – $185 million
2007 – $515 million
Eli
Lilly
2010 – $1.4 billion
2012 – $29 million
2014 – $3 billion
Novartis
2010 – $425 million
Schering-Plough
2002 – $500 million
2004 – $345 million
2006 – $435 million
Takeda
2014 – $6 billion
2015 – $2.5 billion
Purdue
Pharma
2019 – $270 million
*
Mr. Romanoff’s writing has been translated into 32 languages and his
articles posted on more than 150 foreign-language news and politics websites in
more than 30 countries, as well as more than 100 English language platforms.
Larry Romanoff is a retired management consultant and businessman. He has held
senior executive positions in international consulting firms, and owned an
international import-export business. He has been a visiting professor at
Shanghai’s Fudan University, presenting case studies in international affairs
to senior EMBA classes. Mr. Romanoff lives in Shanghai and is currently writing
a series of ten books generally related to China and the West. He is one of the
contributing authors to Cynthia McKinney’s new anthology ‘When China Sneezes’. (Chapt. 2 — Dealing with Demons).
His full archive can be seen at https://www.moonofshanghai.com/ and https://www.bluemoonofshanghai.com/
He can be contacted at: 2186604556@qq.com
*
Notes
(1) https://www.bluemoonofshanghai.com/politics/6004/
Nestlé
– Murdering With Milk
(2) https://corporatewatch.org/five-ways-big-pharma-makes-so-much-money/
Vaccine
Capitalism: Five Ways Big Pharma Makes So Much Money
(3) https://pubmed.ncbi.nlm.nih.gov/10472327/
Cancer
risk associated with simian virus 40 contaminated polio vaccine
(4) https://pubmed.ncbi.nlm.nih.gov/15322523/
Polio
vaccines, Simian Virus 40, and human cancer: the epidemiologic evidence for a
causal association
(5) https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(04)16746-9/fulltext
Monkeys,
viruses, and vaccines
(6) https://abcnews.go.com/Health/wireStory/polio-cases-now-caused-vaccine-wild-virus-67287290
More
polio cases now caused by vaccine than by wild virus
(7) https://money.cnn.com/2003/06/20/news/companies/astra_settlement/
AstraZeneca to pay $355M in fine – Jun. 20, 2003 – CNN
AstraZeneca Resolves Most Seroquel Suits for $647 Million
EU
opens new front in AstraZeneca legal fight that may lead to fines
(10) https://www.corp-research.org/astrazeneca
AstraZeneca: Corporate Rap Sheet
Abbott
Laboratories to pay $1.6 billion over illegal marketing of Depakote
Abbott
Labs to Pay $1.5 Billion to Resolve Criminal & Civil Investigations of
Off-label Promotion of Depakote
(13) https://www.drugwatch.com/manufacturers/abbott-laboratories/
St.
Jude Class Action Lawsuit
Abbott
Hit With Lawsuits As FDA Investigates Androgel Risks
United
States Files False Claims Act Complaint Against Drug Maker Teva Pharmaceuticals
Alleging Illegal Kickbacks
(16) https://www.marlerblog.com/case-news/similac-baby-formula-recalled-due-to-beetle-larvae-and-insects/
Similac
Baby Formula Recalled Due to Beetle Larvae and Insects
(17) https://www.cbsnews.com/news/how-did-beetles-get-into-similac-baby-formula/
How
Did Beetles Get Into Similac Baby Formula? – CBS
Similac
Recall: Bugs in Baby Formula Worry Parents
(19) https://www.justice.gov/archive/atr/public/press_releases/1999/2450.htm
HOFFMANN-LA
ROCHE AND BASF AGREE TO PAY RECORD CRIMINAL FINES FOR PARTICIPATING IN
INTERNATIONAL VITAMIN CARTEL F. HOFFMANN-LA ROCHE AGREES TO PAY $500 MILLION,
HIGHEST CRIMINAL FINE EVER
(20) https://www.reuters.com/article/us-tamiflu-japan-idUST33169820070306
Tamiflu
side effect concerns grow after Japan deaths
(21) https://www.classaction.com/news/arthritis-drug-actemra-deaths/
This
Arthritis Drug Has Been Linked to 1,100 Deaths
Sanofi
faces manslaughter charges in France over yearslong Depakine probe
Dépakine
: Sanofi mis en examen pour homicides involontaires
(24) https://www.france24.com/en/live-news/20220105-class-action-against-sanofi-wins-french-court-backing
Class
action against Sanofi wins French court backing
(25) https://www.mmm-online.com/home/channel/sanofi-aventis-settles-federal-lawsuit-for-182-8-million/
Sanofi-Aventis
settles federal lawsuit for $182.8 million
(26) https://www.cnbc.com/2014/12/03/suit-claims-kickback-scheme-at-sanofi.html
Bad
medicine: Suit claims ‘kickback’ scheme at Sanofi
(27) https://www.cnbc.com/2015/11/20/sanofi-whistleblower-lawsuit-kicks-into-higher-gear.html
Sanofi
whistleblower lawsuit kicks into higher gear
(28) https://www.cnbc.com/2014/12/03/suit-claims-kickback-scheme-at-sanofi.html
Bad
medicine: Suit claims ‘kickback’ scheme at Sanofi
Sanofi
Agrees to Pay $11.85 Million to Resolve Allegations That it Paid Kickbacks
Sanofi-Aventis
settles patent infringement lawsuits with Barr and Teva
Sanofi
Taxotere Eye Injury Lawsuits Sent to Louisiana Courtroom
(32) https://www.aljazeera.com/economy/2021/2/16/bristol-myers-sanofi-to-pay-hawaii-834m-over-plavix
Bristol
Myers Squibb, Sanofi to pay $834m in Plavix case
(33) https://www.policymed.com/2017/03/sanofi-settles-vaccine-antitrust-dispute.html
Sanofi
Settles Vaccine Antitrust Dispute
Sanofi
US Agrees to Pay $109 Million to Resolve False Claims Act Allegations of Free
Product Kickbacks to Physicians
(35) https://www.reuters.com/article/sanofi-bribery-idUKL6N0M01V620140303
Sanofi
pays nearly $40 million upon conviction for paying bribes
(36) https://www.selectjustice.com/medtronic-infuse-bone-graft-lawsuit
Medtronic
Infuse Bone Graft Lawsuit
Medtronic
to Pay Over $9.2 Million To Settle Allegations of Improper Payments to South
Dakota Neurosurgeon
(38) https://www.johnsonbecker.com/medical-device-injuries/medtronic-pacemaker-lawsuit/
Medtronic
Pacemaker Lawsuit
(39) https://www.wsj.com/articles/SB10001424052702304819004579488620836075010
Takeda,
Lilly Ordered to Pay $9 Billion in Diabetes-Drug Case
Maxim
Healthcare Services Charged with Fraud
Copyright
© Larry Romanoff, Moon of Shanghai, Blue Moon of Shanghai,
2022
